Effects of erythromycin on voriconazole pharmacokinetics and association with CYP2C19 polymorphism

被引：0
|
作者：
Hui-Yan Shi
Jin Yan
Wen-Hui Zhu
Guo-Ping Yang
Zhi-Rong Tan
Wei-Hua Wu
Gan Zhou
Xiao-Ping Chen
Dong-Sheng Ouyang
机构：
[1] Central South University,Pharmacogenetics Research Institute, Institute of Clinical Pharmacology
[2] Central South University,Third Xiangya Hospital
[3] Central South University,Department of Pharmacology, School of Pharmaceutical Science
来源：
European Journal of Clinical Pharmacology | 2010年 / 66卷
关键词：
Voriconazole; Erythromycin; CYP2C19; Genetic polymorphism; Chinese;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1131 / 1136
页数：5
相关论文
共 50 条
  • [1] Effects of erythromycin on voriconazole pharmacokinetics and association with CYP2C19 polymorphism
    Shi, Hui-Yan
    Yan, Jin
    Zhu, Wen-Hui
    Yang, Guo-Ping
    Tan, Zhi-Rong
    Wu, Wei-Hua
    Zhou, Gan
    Chen, Xiao-Ping
    Ouyang, Dong-Sheng
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (11) : 1131 - 1136
  • [2] EFFECTS OF CYP2C19 GENOTYPES AND CYP3A4 INHIBITOR ERYTHROMYCIN ON VORICONAZOLE PHARMACOKINETICS
    Ouyang, Dong-sheng
    Shi, Hui-yan
    Zhou, Honghao
    DRUG METABOLISM REVIEWS, 2008, 40 : 30 - 31
  • [3] IMPACT OF CYP2C19 POLYMORPHISM ON THE PHARMACOKINETICS OF TACROLIMUS WHEN CO-ADMINISTERED WITH VORICONAZOLE.
    Furihata, K.
    Imamura, C. K.
    Kojima, H.
    Kusayama, S.
    Ogoe, K.
    Hashimoto, N.
    Okamoto, S.
    Tanigawara, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S27 - S27
  • [4] Effect of CYP2C19 Polymorphism on the Pharmacokinetics of Voriconazole After Single and Multiple Doses in Healthy Volunteers
    Lee, SeungHwan
    Kim, Bo-Hyung
    Nam, Won-Seok
    Yoon, Seo Hyun
    Cho, Joo-Youn
    Shin, Sang-Goo
    Fang, In -Jin
    Yu, Kyung-Sang
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (02): : 195 - 203
  • [5] Effects of CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy subjects
    Cho, Chang-Keun
    Byeon, Ji-Young
    Kang, Pureum
    Park, Hye-Jung
    Ko, Eunvin
    Mu, Chou Yen
    Jang, Choon-Gon
    Lee, Seok-Yong
    Lee, Yun Jeong
    ARCHIVES OF PHARMACAL RESEARCH, 2023, 46 (02) : 111 - 116
  • [6] Effects of CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy subjects
    Chang‑Keun Cho
    Ji-Young Byeon
    Pureum Kang
    Hye-Jung Park
    Eunvin Ko
    Chou Yen Mu
    Choon-Gon Jang
    Seok-Yong Lee
    Yun Jeong Lee
    Archives of Pharmacal Research, 2023, 46 : 111 - 116
  • [7] Pharmacokinetics of citalopram in relation to genetic polymorphism of CYP2C19
    Yu, BN
    Chen, GL
    He, N
    Ouyang, DS
    Chen, XP
    Liu, ZQ
    Zhou, HH
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (10) : 1255 - 1259
  • [8] Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19
    Wang, JH
    Liu, ZQ
    Wang, W
    Chen, XP
    Shu, Y
    He, N
    Zhou, HH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 70 (01) : 42 - 47
  • [9] Effects of CYP2C19 genetic polymorphism on the pharmacokinetics and pharmacodynamics of omeprazole in Chinese people
    Hu, Xiang-Peng
    Xu, Jian-Ming
    Hu, Yong-Mei
    Mei, Qiao
    Xu, Xin-Hua
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2007, 32 (05) : 517 - 524
  • [10] COMPARISON OF THE PHARMACOKINETICS BETWEEN TWO VORICONAZOLE FORMULATIONS AND THE EFFECT OF CYP2C19 POLYMORPHISMS ON VORICONAZOLE EXPOSURE
    Han, HyeKyung
    Lee, Jieon
    Shin, Kwang-Hee
    Ji, Sang Chun
    Cho, Joo-Youn
    Lim, Kyoung Soo
    Jang, In-Jin
    Yu, Kyung-Sang
    DRUG METABOLISM REVIEWS, 2014, 45 : 43 - 43
12345